Multiple endocrine neoplasia type 1: latest insights
ML Brandi, SK Agarwal, ND Perrier, KE Lines… - Endocrine …, 2021 - academic.oup.com
Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …
autosomal dominant pattern, is continuing to raise great interest for endocrinology …
Clinical aspects of multiple endocrine neoplasia type 1
A Al-Salameh, G Cadiot, A Calender… - Nature Reviews …, 2021 - nature.com
Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome characterized by the co-
occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours …
occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours …
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)
RV Thakker, PJ Newey, GV Walls… - The Journal of …, 2012 - academic.oup.com
Objective: The aim was to provide guidelines for evaluation, treatment, and genetic testing
for multiple endocrine neoplasia type 1 (MEN1). Participants: The group, which comprised …
for multiple endocrine neoplasia type 1 (MEN1). Participants: The group, which comprised …
Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis
CDC Kamilaris, CA Stratakis - Frontiers in endocrinology, 2019 - frontiersin.org
Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary tumor syndrome inherited in
an autosomal dominant manner and characterized by a predisposition to a multitude of …
an autosomal dominant manner and characterized by a predisposition to a multitude of …
Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine …
B Niederle, A Selberherr, DK Bartsch, ML Brandi… - …, 2021 - karger.com
The better understanding of the biological behavior of multiple endocrine neoplasia type 1
(MEN1) organ manifestations and the increase in clinical experience warrant a revision of …
(MEN1) organ manifestations and the increase in clinical experience warrant a revision of …
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
I Coutinho, TK Day, WD Tilley… - Endocrine-related …, 2016 - erc.bioscientifica.com
The androgen receptor (AR) signaling axis drives all stages of prostate cancer, including the
lethal, drug-resistant form of the disease termed castration-resistant prostate cancer (CRPC) …
lethal, drug-resistant form of the disease termed castration-resistant prostate cancer (CRPC) …
MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines
P Goudet, A Dalac, M Le Bras… - The Journal of …, 2015 - academic.oup.com
Context: Multiple endocrine neoplasia Type-1 (MEN1) in young patients is only described by
case reports. Objective: To improve the knowledge of MEN1 natural history before 21 years …
case reports. Objective: To improve the knowledge of MEN1 natural history before 21 years …
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with …
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients
JM De Laat, RB van der Luijt, CRC Pieterman… - BMC medicine, 2016 - Springer
Abstract Background Multiple Endocrine Neoplasia type 1 (MEN1) is diagnosed when two
out of the three primary MEN1-associated endocrine tumors occur in a patient. Up to 10 …
out of the three primary MEN1-associated endocrine tumors occur in a patient. Up to 10 …
Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Neuroendocrine tumors (NETs) of the lung comprise a heterogeneous population of tumors
ranging from welldifferentiated bronchial NETs to highly malignant and poorly differentiated …
ranging from welldifferentiated bronchial NETs to highly malignant and poorly differentiated …